TOBAM’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
9,584
-12,428
| -56% | -$1.56M | 0.47% | 57 |
|
|
2025
Q1 | $2.44M | Sell |
22,012
-9,256
| -30% | -$1.02M | 1.04% | 34 |
|
|
2024
Q4 | $4.27M | Sell |
31,268
-41,978
| -57% | -$5.73M | 1.3% | 27 |
|
|
2024
Q3 | $8.44M | Sell |
73,246
-17,219
| -19% | -$1.98M | 1.54% | 21 |
|
|
2024
Q2 | $12.5M | Sell |
90,465
-87,788
| -49% | -$12.1M | 1.95% | 17 |
|
|
2024
Q1 | $24.6M | Sell |
178,253
-48,588
| -21% | -$6.7M | 2.2% | 18 |
|
|
2023
Q4 | $29.9M | Sell |
226,841
-70,343
| -24% | -$9.27M | 2.61% | 9 |
|
|
2023
Q3 | $33.4M | Sell |
297,184
-14,531
| -5% | -$1.63M | 2.68% | 8 |
|
|
2023
Q2 | $29.4M | Sell |
311,715
-50,689
| -14% | -$4.78M | 2.22% | 15 |
|
|
2023
Q1 | $36.7M | Buy |
362,404
+74,564
| +26% | +$7.55M | 2.42% | 11 |
|
|
2022
Q4 | $34.4M | Buy |
287,840
+969
| +0.3% | +$116K | 2.28% | 13 |
|
|
2022
Q3 | $30.5M | Sell |
286,871
-19,623
| -6% | -$2.08M | 2.13% | 15 |
|
|
2022
Q2 | $29.9M | Buy |
306,494
+90,037
| +42% | +$8.78M | 1.87% | 19 |
|
|
2022
Q1 | $20.3M | Buy |
216,457
+24,704
| +13% | +$2.32M | 1.02% | 36 |
|
|
2021
Q4 | $16.3M | Buy |
191,753
+66,588
| +53% | +$5.67M | 0.73% | 51 |
|
|
2021
Q3 | $12M | Sell |
125,165
-49
| -0% | -$4.7K | 0.51% | 64 |
|
|
2021
Q2 | $12.2M | Buy |
125,214
+29,810
| +31% | +$2.9M | 0.49% | 65 |
|
|
2021
Q1 | $9.28M | Buy |
95,404
+35,249
| +59% | +$3.43M | 0.39% | 71 |
|
|
2020
Q4 | $5.77M | Buy |
60,155
+28,849
| +92% | +$2.77M | 0.26% | 85 |
|
|
2020
Q3 | $3.01M | Sell |
31,306
-23,350
| -43% | -$2.25M | 0.15% | 99 |
|
|
2020
Q2 | $6.67M | Sell |
54,656
-3,452
| -6% | -$421K | 0.43% | 62 |
|
|
2020
Q1 | $5.03M | Buy |
58,108
+36,315
| +167% | +$3.14M | 0.4% | 62 |
|
|
2019
Q4 | $2.34M | Buy |
21,793
+17,614
| +421% | +$1.89M | 0.14% | 82 |
|
|
2019
Q3 | $377K | Buy |
4,179
+529
| +14% | +$47.7K | 0.02% | 93 |
|
|
2019
Q2 | $308K | Buy |
3,650
+511
| +16% | +$43.1K | 0.02% | 95 |
|
|
2019
Q1 | $277K | Buy |
3,139
+1,369
| +77% | +$121K | 0.01% | 117 |
|
|
2018
Q4 | $126K | Buy |
+1,770
| New | +$126K | 0.01% | 143 |
|